N-hydroxyamide-containing heterocycles: Synthesis, reactivities, and iron(III)-chelating properties

Reviews on Heteroatom Chemistry

Volumn 18, Issue , 1998, Pages 87-118

  Ohkanda, Junko ^a   Katoh, Akira ^a  

^a SEIKEI UNIVERSITY   (Japan)

Author keywords

Absolute configuration; Acylating agent; Iron complex; N hydroxy 2(1H) pyrazinone; N hydroxy 2(1H) pyrimidinone; Photoreaction; Ring transformation; Siderophore; Stability constant; Transferrin

Indexed keywords

EID: 0032221029     PISSN: 09156151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. G. Winkelmann, D. van der Helm and J. B. Neilands: Iron Transport in Microbes, Plant and Animals (VCH, Weinheim, 1987).
2. G. Winkelmann: Handbook of Microbial Iron Chelates (CRC Press, Boca Raton, 1991).
3. R. J. Bergeron and G. M. Brittenham: The Development of Iron Chelators for Clinical Use (CRC Press, Boca Raton, 1992).
4. R. Behrend and K. Leuchs: Justus Liebigs Ann. Chem. 257 203 (1890).
5. J. Ohkanda, T. Tokumitsu, K. Mitsuhashi and A. Katoh: Bull. Chem. Soc. Jpn. 66 841 (1993).
6. J. R. Vaughan, Jr. and R. L. Osato: J. Am. Chem. Soc. 74 676 (1952).
7. C. Kashima, A. Katoh, Y. Yokota and Y. Omote: Chem. Pharm. Bull. 29 2516 (1981).
8. A. Katoh, J. Ohkanda, A. Tamura, Y. Yoshiike and K. Mitsuhashi: Heterocycles 37 1141 (1994).
9. MOPAC Ver. 5.00 (QCPE No. 445): J. J. Stewart: QCPE Bull. 9 10 (1989); T. Hirano: JCPE Newsletter 1 36 (1989); Revised as Ver. 5.01 by J. Toyoda, for Apple Macintosh.
10. MOPAC Ver. 5.00 (QCPE No. 445): J. J. Stewart: QCPE Bull. 9 10 (1989); T. Hirano: JCPE Newsletter 1 36 (1989); Revised as Ver. 5.01 by J. Toyoda, for Apple Macintosh.
11. MOPAC Ver. 5.00 (QCPE No. 445): J. J. Stewart: QCPE Bull. 9 10 (1989); T. Hirano: JCPE Newsletter 1 36 (1989); Revised as Ver. 5.01 by J. Toyoda, for Apple Macintosh.
12. E. Lipczynska-Kochany:Chem. Rev. 91 477 (1991)
13. H. Furrer: Tetrahedron Lett. 2953 (1974).
14. A. R. Katrizky, A. V. Chapman, M. J. Cook and G. H. Millet: J. Chem. Soc., Perkin Trans. 1 2743 (1980).
15. T. Sakurai, Y. Takeda and H. Inoue: Nippon Kagaku Kaishi 1 (1984).
16. J. Ohkanda, T. Kumasaka, A. Takasu, T. Hasegawa and A. Katoh: Heterocycles 43 883 (1996).
17. The MO calculations were performed on Macintosh Quadra 950 with coprocessor CXP40M using PM3 in CAChe (Ver. 3.6).
18. A. R. Katritzky and M. F. Gordeev: J. Chem. Soc., Perkin Trans. 1 2199 (1991).
19. A. I. Meyer: Heterocycles in Organic Synthesis (John Wiley & Sons, New York 1974) vol. 3.
20. Y. Okuwaki, Y. Yanagawa, H. Tamamura, T. Suzuki, H. Kuwana, M. Tahara, K. Yuasa and A. Ohta: J. Heterocycl. Chem. 24 187 (1987).
21. D. H. Rich and J. Singh: The Peptides, (Eds.) E. Gross and J. Meienhofer (Academic Press, New York, 1979) vol.1 pp. 242-262.
22. A. Katoh, J. Ohkanda, Y. Itoh and K. Mitsuhashi: Chem. Lett. 2009 (1992).
23. W. König and R. Geiger: Chem. Ber. 103 788 (1970).
24. B. Halpern, L. F. Chew and B. Weinstein: J. Am. Chem. Soc. 89 5051 (1967).
25. B. Weinstein and A. E. Prichard: J. Chem. Soc., Perkin Trans. 1 1015 (1972).
26. K. Kawasaki, T. Tsuji, K. Hirase, M. Miyano, Y. Imote and M. Iwamoto: Chem. Pharm. Bull. 39 584 (1991).
27. R. Geiger and W. König: The Peptides, (Eds.) E. Gross and J. Meienhofer (Academic Press, New York, 1981) vol. 3 pp. 1-88.
28. T. W. Greene and P. G. M. Wuts: Protective Groups in Organic Synthesis (John Wiley & Sons, New York, 1991).
29. S. Kim and J . I. Lee: Chem. Lett. 237 (1984).
30. T. Nagasawa, K. Kuroiwa, K. Narita and Y. Isowa:. Bull. Chem. Soc. Jpn. 46 1269 (1973).
31. A. Ohta, M. Shimazaki, H. Tamamura, Y. Mamiya and T. Watanabe: J. Heterocycl. Chem. 20 951 (1983).
32. A. Ohta, Y. Inagawa, M. Inoue, M. Shimazaki and Y. Mamiya,: J. Heterocycl. Chem. 22 1173 (1985).
33. A. Ohta, Y. Inagawa and C. Mitsugi:. J. Heterocycl. Chem. 22 1643 (1985).
34. A. Katoh, S. Kondoh and J. Ohkanda: Heterocyclic Commun. 2 141 (1996).
35. Y. Kita, J. Haruta, K. Fukunaga, Y. Shirouchiand and Y. Tamura: J. Org. Chem. 47 2697 (1982).
36. S. T. Callender and D. J. Weatherall: Lancet Sept. 27 689 (1980).
37. A. Jacobs and W. C. Ting: Lancet Oct. 11 794 (1980).
38. C. Kattamis, J. Fitsialos and C. Sinopoulou: Lancet Jan. 3 51 (1981).
39. M. R. Summers, A. Jacobs, D. Tudway, P. Perera and C. Rickett: Br. J. Haematol. 42 547 (1979).
40. M. J. Miller and F. Malouin: The Development of Iron Chelators for Clinical Use, (Eds.) R. J. Bergeron and G. M. Brittenham (CRC Press: Boca Raton, 1992) pp. 277.
41. Y. Sun, A. E. Martell, J. Reibenspies and M. J. Welch: Tetrahedron 47 357 (1991).
42. R. J. Motekaitis, Y. Sun and A. E. Martell: Inorg. Chim. Acta 198 421 (1992).
43. Y. Sun, A. E. Martell and M. J. Welch: Tetrahedron 47 8863 (1991).
44. R. C. Scarrow, P. E. Riely, K. Abu-Dari, D. L. White and K. N. Raymond: Inorg. Chem. 24 954 (1985).
45. R. C. Scarrow, D. L. White and K. N. Raymond: J. Am. Chem. Soc. 107 6540 (1985).
46. R. C. Hider, G. J. Kontoghiorghes and J. Silver: UK Patent: GB-2118176 (1982).
47. R. C. Hider, S. Singh, J. B. Porter and E. R. Huehns: Ann. N. Y. Acad. Sci. 612 327 (1990).
48. R. J. Motekaitis and A. E. Martell: Inorg. Chim. Acta 183 71 (1991).
49. E. T. Clarke and A. E. Martell: Inorg. Chim. Acta 191 57 (1992).
50. L. N. Sheppard and G. J. Kontoghioghes: Inorg. Chim. Acta 188 177 (1991).
51. B. Faller and H. J. Nick: J. Am. Chem. Soc. 116 3860 (1994).
52. R. C. Scarrow and K. N. Raymond: Inorg. Chem. 27 4140 (1988).
53. M. Streater, P. D. Taylor, R. C. Hider and J. Porter: J. Med. Chem. 33 1749 (1990).
54. E. T. Clarke and A. E. Martell: Inorg. Chim. Acta 196 185 (1992).
55. N. F. Olivieri, D. M. Templeton, G. Koren, D. Chung, C. Hermann, M. H. Freedman and R. A. McClelland: Ann. N.Y. Acad. Sci. 612 369 (1990).
56. P. Tondury, G. J. Kontoghiorghes, A. Ridolfi-Luthy, A. Hirt, A. V. Hoffbrand, A. M. Lottenbach, T. Sonderegger and H. P. Wagner: Br. J. Haematol. 76 550 (1990).
57. F. N. Al-Refaie, B. Wonke, A. V. Hoffbrand, D. G. Wickens, P. Nortey and G. J. Kontoghiorghes: Blood 80 593 (1992).
58. Y. Sun and A. E. Martell: The Development of Iron Chelators for Clinical Use, (Eds.) R. J. Bergeron and G. M. Brittenham (CRC Press, Boca Raton, 1992) pp.345.
59. J. Ohkanda, J. Kamitani, T. Tokumitsu, Y. Hida, T. Konakahara and A. Katoh: J. Org. Chem. 62 3618 (1997).
60. W. Klotzer: Monatsh. Chem. 95 1729 (1964).
61. M. R. Harden, L. J. Jennings and A. Parkin: J. Chem. Soc., Perkin Trans. 1 2175 (1990).
62. G. Anderegg, F. L'Eplattenier and G. Schwarzenbach: Helv. Chim. Acta 46 1400 and 1409 (1963).
63. C. J. Carrano and K. N. Raymond: J. Am. Chem. Soc. 101 5401 (1979).
64. The MM2 and MD calculations were performed on Macintosh Quadra 950 with coprocessor CXP40M using MM2 in CAChe (Ver. 3.6) argumented MM2 force field (CAChe Scientific) and MD in CAChe (Ver 3.6).
65. E. N. Baker, B. F. Anderson and H. M. Baker: Int. J. Biol. Macromol. 13 122 (1991).
66. S. A. K. Nguyen, A. Craig and K. N. Raymond: J. Am. Chem. Soc. 115 6758 (1993).
67. J. Ohkanda and A. Katoh: Tetrahedron 51 12995 (1995).
68. J. Ohkanda and A. Katoh: J. Org. Chem. 60 1583 (1995).
69. D. van der Helm, J. R. Baker, D. L. Eng-Wilmont, M. B. Hossain and R. A. Loghry: J. Am. Chem. Soc. 102 4224 (1980).
70. C. J. Carrano and K. N. Raymond: J. Am. Chem. Soc. 100 5371 (1978).
71. K. N. Raymond, G. Muller and B. F. Matzanke: Top. Curr. Chem. 123 49 (1984).
72. Y. Tor, J. Libman, A. Shanzer, C. E. Felder and S. Lifson: J. Am. Chem. Soc. 114 6661 (1992).
73. I. Dayan, J. Libman, Y. Agi and A. Shanzer: Inorg. Chem. 32 1467 (1993).
74. S. A. Kretchmar, Z. E. Reyes and K. N. Raymond: Biochim. Biophys. Acta 956 85 (1988).
75. S. A. Krechmar and K. N. Raymond: J. Am. Chem. Soc. 108 6212 (1986).
76. E. Cowart, N. Kojima and G. W. Bates: J. Biol. Chem. 101 5401 (1982).
77. J. Ohkanda and A. Katoh: Chem. Lett. 423 (1996).
78. J. Ohkanda: Ph. D. thesis, The University of Tokyo (1996).